Navigation Links
Vyopta Granted Cisco Preferred Solution Developer Partner Status, Highest Level for Cisco Developer Network
Date:3/11/2013

Austin, Texas (PRWEB) March 11, 2013

To take advantage of the benefits of the expanding role of the network, Vyopta Incorporated, the leading developer of business intelligence and process automation applications for video collaboration, today announced that it is now a Preferred Solution Developer within the TelePresence and Collaboration technology category of Cisco’s Developer Network Program.

Vyopta software applications (vAnalytics™, vAccess™, vPublish™, vSchedule™ and vControl®) fuse business video products into end-to-end solutions that transform the way companies utilize video. Vyopta solutions set the standard in quality, scalability and robust capabilities to support a variety of customer use cases, from automation and management of workflows for video collaboration, lecture capture and publishing, to powerful business analytics that transform the way companies measure the impact of video on their business.

The Cisco Developer Network unites Cisco with third-party developers of hardware and software to deliver tested interoperable solutions to joint customers, harnessing the power and intelligence of the network. As a Preferred Solution Developer, Vyopta has worked closely with Cisco to deliver enhanced solutions that deliver greater interoperability with Cisco networking solutions. Vyopta also shares Cisco’s strong commitment to customer service and satisfaction, has completed interoperability verification testing based on criteria set forth by Cisco, and can provide their customers comprehensive support. With Vyopta products, customers can more quickly deploy a broad range of Cisco Compatible business applications, devices, or services that can enhance the capabilities, performance, and management of the Cisco network. For more information on Vyopta interoperability with Cisco, visit http://www.vyopta.com.

“We are proud to have achieved Preferred Solution Developer Partner Status with Cisco,” said Alfredo Ramirez, President and CEO of Vyopta. “Teaming with Cisco further enables customers to benefit from interoperable solutions that transform how they collaborate, sell, educate, deliver patient care, and more.”

About Vyopta Incorporated
Vyopta is the leading developer of applications for video collaboration, enabling operations intelligence, customer service and content publishing automation that unleash the power of interactive video communications. Vyopta enables companies to do more with video – revolutionizing the way they sell, service, communicate and innovate. For more information on Vyopta, visit http://www.vyopta.com.

  • Interoperability testing is designed to simulate typical customer configurations, and does not replace the need for on-site testing in conjunction with actual implementation.

Vyopta and vControl are registered trademarks of Vyopta Incorporated, and the trademarks of the Vyopta family of products are trademarks of Vyopta Incorporated. All other trademarks referenced herein are the property of their respective owners.

Read the full story at http://www.prweb.com/releases/2013/VyoptaCDN/prweb10497051.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Tired Couples May Take Each Other For Granted
2. Trustifi Patent 8,341,023 Granted by USPTO and New Patent to be Issued for Postmarked Email
3. Professional Healthcare at Home Offering Geriatric Care Management Services in the San Francisco Bay Area
4. Fast Growing San Francisco Chiropractic Clinic Welcomes New Doctor, Dr. Anthony Gustin
5. Sean Sullivan San Francisco Real Estate New Construction: Discusses ”The Heights” In Pacific Heights, 14 New Luxury Condos
6. Damaka introduces Xabr™, a Native Mobile Video & Collaboration Client for Cisco® Jabber®, CallManager, and TelePresence
7. Paramount Lists Will Be Speaking At The National Postal Forum In San Francisco
8. Using an HRA to Comply with San Francisco's HCSO Requirements - Zane Benefits Publishes Information
9. American Society of Human Genetics to hold 2012 annual meeting, Nov. 6 to 10, in San Francisco
10. San Francisco is Hosting EB-5 Conference July 19, 2012
11. Special Needs Spotlight: Former SFMTA Board Member Bruce Oka Receives Treatment with San Francisco Sedation Dentist Dr. David Blende
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/12/2016)... ... February 12, 2016 , ... Itopia, a ... the integration of Clarity Intelligence Platform (CIP) into Cielo®, a discovery, migration and ... intelligence (BI) to their small and medium business (SMB) clients. , ...
(Date:2/12/2016)... ... 12, 2016 , ... Vail knee specialist Robert LaPrade, MD, PhD ... . The list consists of physicians establishing, leading and partnering with ambulatory surgery centers ... An Ambulatory Surgery Center, also known as an ASC, is a modern health care ...
(Date:2/12/2016)... , ... February 12, 2016 , ... For Coast Dental ... Suzan Sweeney, RDH, and dental assistant Terrell Moore shortly before 7 a.m. to volunteer ... of dental professionals, donating their time and skills to help hundreds of uninsured and ...
(Date:2/12/2016)... Malvern, Pa. (PRWEB) , ... February 12, 2016 ... ... help sort through a world of exterior design possibilities. CertainTeed, North America’s leading ... visualization tools by expanding the product offerings showcased in the mobile version of ...
(Date:2/12/2016)... (PRWEB) , ... February 12, 2016 , ... ... creating explosive growth in the field of long term care. With that, says ... for well-trained healthcare professionals in administrative roles in long term care environments. His ...
Breaking Medicine News(10 mins):
(Date:2/12/2016)... --> ... Global Clinical Trials Review, H2, 2015 provides an ... trials landscape along with top level data related ... & E7), Trial Status, Trial Phase, Sponsor Type ... involved and enlists all trials (Trial title, Phase, ...
(Date:2/11/2016)... 11, 2016 Stem cells are primitive cells ... self-renewal and the capacity to differentiate into mature cell ... as the first mouse embryonic stem cells were derived ... 1995 that the first culturing of embryonic stem cells ... not produced until 2006 As a result of these ...
(Date:2/11/2016)... -- Kindred Biosciences, Inc. (NASDAQ: KIN ), a biopharmaceutical ... pets, today announced the submission to FDA of the ... (NADA) for Zimeta™ (dipyrone injection, KIND-012).  Positive topline results ... the control of pyrexia (fever) in horses were recently ... --> The Chemistry, Manufacturing, and Controls technical ...
Breaking Medicine Technology: